Biotech Blog

Biotech Blog

Biotech Blog Archives: February 2008

·

26 February 2008

Generic Biologics: How to Compete

Guest content from John Avellanet, managing director and principal of Cerulean Associates:

Follow-on biologics are a foregone conclusion in the US. Too much money is at stake. The more difficult discussion starts with how to prepare your company to compete.
Science Succumbs to Dollars
The financial pull on reimbursement organizations and the constituent push on [...]

continue reading... » One Comment

25 February 2008

BIO’s website hacked?

Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section had been hacked. No evidence of tampering elsewhere on the site, but all the news releases have been tagged by the hackers.

continue reading... » One Comment

18 February 2008

Upcoming talk: Forget everything you thought you knew about biotechnology entrepreneurship

I’ll be at Rutgers on February 29th, giving a talk on biotechnology entrepreneurship. My objective is to dispel the popular notions about how biotechnology entrepreneurship occurs, and to provide case studies demonstrating the diversity of methods by which biotechnology entrepreneurs start and build their businesses. I’ll also provide some case studies of significant mis-steps, [...]

continue reading... » 2 Comments

10 February 2008

An appeal for generic biologic legislation

The following appeal for generic biologic legislation was sent in from Insmed via youtube.
I’ve posted previously on the challenges of developing a framework for generic biologic approvals and questioned how much we can really expect to save. In the editorial for the upcoming issue of the Journal of Commercial Biotechnology, I argue that the United [...]

continue reading... » 0 Comments

4 February 2008

Drug Patent Expirations in February 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in February 2008*Drugs may be
covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

CAMPTOSAR
Pfizer Inc
irinotecan hydrochloride
4,604,463
FEB 20,2008

CIPRO HC
Alcon
ciprofloxacin hydrochloride; hydrocortisone
4,844,902
FEB 11,2008

CIPRODEX
Alcon
ciprofloxacin; dexamethasone
4,844,902
FEB 11,2008

DEPOCYT
Pacira Pharms Inc
cytarabine
6,071,534
FEB 18,2008

DEPODUR
Pacira Pharms Inc
morphine sulfate
6,071,534
FEB 18,2008

FOSAMAX
Merck
alendronateLe but de poker pacific. sodium
4,621,077
FEB 06,2008

FOSAMAX PLUS D
Merck
alendronate sodium; cholecalciferol
4,621,077
FEB 06,2008

INSPRA
Gd Searle Llc
eplerenone
4,559,332
FEB 11,2008

LOTEMAX
Pharmos
loteprednol etabonate
4,996,335
FEB 26,2008

TESLASCAN
Ge Healthcare
mangafodipir trisodium
4,992,554
FEB 12,2008

Courtesy of DrugPatentWatch.com

continue reading... » 0 Comments

·